Erratum: Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation (Nature Communications (2014) 5 (3986) (DOI:10.1038/ncomms4986));Differential developmental requirement and peripheral regulation for dermal Vγ34 and Vγ36T17 cells in health and inflammation

Nature Communications

Volumn 5, Issue , 2014, Pages

  Cai, Yihua ^a   Xue, Feng ^b   Fleming, Chris ^a   Yang, Jie ^c   Ding, Chuanlin ^a   Ma, Yunfeng ^a   Liu, Min ^a   Zhang, Huang Ge ^a   Zheng, Jie ^b   Xiong, Na ^c   Yan, Jun ^a  

^a University of Louisville School of Medicine   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 23; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR;

CELL ORGANELLE; EMBRYO; RODENT; SIGNALING; SKIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMAL GAMMA DELTA T LYMPHOCYTE; DERMAL V GAMMA 4 T LYMPHOCYTE; DERMAL V GAMMA 6 TH17 LYMPHOCYTE; DERMATITIS; FETUS DEVELOPMENT; GAMMA DELTA T LYMPHOCYTE; GENOME IMPRINTING; HOMEOSTASIS; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; LYMPHOPOIESIS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRE T LYMPHOCYTE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN CELL; THYMUS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; SKIN;

ANIMALS; CELL PROLIFERATION; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; SKIN;

EID: 84902279613     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11354     Document Type: Erratum

References (46)

1. Di Meglio, P., Perera, G. K. & Nestle, F. O. The multitasking organ: recent insights into skin immune function. Immunity 35, 857-869 (2011).
2. Payer, E., Elbe, A. & Stingl, G. Epidermal T lymphocytes-ontogeny, features and function. Springer Semin. Immunopathol. 13, 315-331 (1992).
3. Sharp, L. L., Jameson, J. M., Cauvi, G. & Havran, W. L. Dendritic epidermal T cells regulate skin homeostasis through local production of insulin-like growth factor 1. Nat. Immunol. 6, 73-79 (2005). (Pubitemid 40136698)
4. Cai, Y. et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation. Immunity 35, 596-610 (2011).
5. Gray, E. E., Suzuki, K. & Cyster, J. G. Cutting edge: Identification of a motile IL-17-producing gammadelta T cell population in the dermis. J. Immunol. 186, 6091-6095 (2011).
6. Sumaria, N. et al. Cutaneous immunosurveillance by self-renewing dermal {gamma}{delta} T cells. J. Exp. Med. 208, 505-518 (2011).
7. Pantelyushin, S. et al. Rorgammat+ innate lymphocytes and gammadelta T cells initiate psoriasiform plaque formation in mice. J. Clin. Invest. 122, 2252-2256 (2012).
8. Becher, B. & Pantelyushin, S. Hiding under the skin: interleukin-17-producing gammadelta T cells go under the skin? Nat. Med. 18, 1748-1750 (2012).
9. Havran, W. L. & Allison, J. P. Origin of Thy-1+ dendritic epidermal cells of adult mice from fetal thymic precursors. Nature 344, 68-70 (1990).
10. Do, J. S. et al. Cutting edge: spontaneous development of IL-17-producing gamma delta T cells in the thymus occurs via a TGF-beta 1-dependent mechanism. J. Immunol. 184, 1675-1679 (2010).
11. Haas, J. D. et al. Development of interleukin-17-producing gammadelta T cells is restricted to a functional embryonic wave. Immunity 37, 48-59 (2012).
12. Turchinovich, G. & Hayday, A. C. Skint-1 identifies a common molecular mechanism for the development of interferon-gamma-secreting versus interleukin-17-secreting gammadelta T cells. Immunity 35, 59-68 (2011).
13. Gray, E. E. et al. Deficiency in IL-17-committed V4 gammadelta T cells in a spontaneous Sox13-mutant CD45.1 congenic mouse substrain provides protection from dermatitis. Nat. Immunol. 14, 584-592 (2013).
14. Malhotra, N. et al. A network of high-mobility group box transcription factors programs innate interleukin-17 production. Immunity 38, 681-693 (2013).
15. Kisielow, J., Kopf, M. & Karjalainen, K. SCART scavenger receptors identify a novel subset of adult gammadelta T cells. J. Immunol. 181, 1710-1716 (2008).
16. Gatzka, M. et al. Reduction of CD18 promotes expansion of inflammatory gammadelta T cells collaborating with CD4+ T cells in chronic murine psoriasiform dermatitis. J. Immunol. 191, 5477-5488 (2013).
17. Jiang, X., Campbell, J. J. & Kupper, T. S. Embryonic trafficking of gammadelta T cells to skin is dependent on E/P selectin ligands and CCR4. Proc. Natl Acad. Sci. USA 107, 7443-7448 (2010).
18. Jin, Y. et al. Cutting edge: Intrinsic programming of thymic gammadelta T cells for specific peripheral tissue localization. J. Immunol. 185, 7156-7160 (2010).
19. Jin, Y., Xia, M., Sun, A., Saylor, C. M. & Xiong, N. CCR10 is important for the development of skin-specific gammadeltaT cells by regulating their migration and location. J. Immunol. 185, 5723-5731 (2010).
20. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J. Immunol. 182, 5836-5845 (2009).
21. Kupper, T. S. et al. Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cellderived thymocyte-activating factor is identical to interleukin 1. J. Exp. Med. 164, 2095-2100 (1986). (Pubitemid 17217988)
22. Matsushima, H. et al. Intravital imaging of IL-1beta production in skin. J. Invest. Dermatol. 130, 1571-1580 (2010).
23. Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496-509 (2009).
24. Dombrowski, Y. et al. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci. Transl. Med. 3, 82ra38 (2011).
25. Hedrick, M. N. et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119, 2317-2329 (2009).
26. Mabuchi, T. et al. CCR6 is required for epidermal trafficking of gammadelta-T cells in an IL-23-induced model of psoriasiform dermatitis. J. Invest. Dermatol. 133, 164-171 (2013).
27. Chan, J. R. et al. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J. Exp. Med. 203, 2577-2587 (2006). (Pubitemid 44833335)
28. Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat. Rev. Immunol. 13, 88-100 (2013).
29. Zeng, X. et al. gammadelta T cells recognize a microbial encoded B cell antigen to initiate a rapid antigen-specific interleukin-17 response. Immunity 37, 524-534 (2012).
30. Chien, Y. H., Zeng, X. & Prinz, I. The natural and the inducible: interleukin (IL)-17-producing gammadelta T cells. Trends Immunol. 34, 151-154 (2013).
31. Tsuda, J. et al. Involvement of CD56bright CD11c+ cells in IL-18-mediated expansion of human gammadelta T cells. J. Immunol. 186, 2003-2012 (2011).
32. Haas, J. D. et al. CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Eur. J. Immunol. 39, 3488-3497 (2009).
33. Liang, D. et al. IL-23 receptor expression on gammadelta T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis. J. Immunol. 191, 1118-1125 (2013).
34. Homey, B. et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621-6632 (2000). (Pubitemid 30408849)
35. Schirmer, L., Rothhammer, V., Hemmer, B. & Korn, T. Enriched CD161high CCR6+ gammadelta T cells in the cerebrospinal fluid of patients with multiple sclerosis. JAMA Neurol. 70, 345-351 (2013).
36. Serre, K. & Silva-Santos, B. Molecular Mechanisms of Differentiation of Murine Pro-Inflammatory gammadelta T cell subsets. Front. Immunol. 4, 431 (2013).
37. Mabuchi, T. et al. CCR6 is required for epidermal trafficking of gammadelta-T cells in an IL-23-induced model of psoriasiform dermatitis. J. Invest. Dermatol. 133, 164-171 (2013).
38. Hedrick, M. N., Lonsdorf, A. S., Hwang, S. T. & Farber, J. M. CCR6 as a possible therapeutic target in psoriasis. Expert Opin. Ther. Targets 14, 911-922 (2010).
39. Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496-509 (2009).
40. Renne, J., Schäfer, V., Werfel, T. & Wittmann, M. Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br. J. Dermatol. 162, 1198-1205 (2010).
41. Johansen, C., Moeller, K., Kragballe, K. & Iversen, L. The activity of caspase-1 is increased in lesional psoriatic epidermis. J. Invest. Dermatol. 127, 2857-2864 (2007). (Pubitemid 350134819)
42. Shepherd, J. & Little, M. C. Nicklin MJH. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. J. Invest. Dermatol. 122, 665-669 (2004). (Pubitemid 38471334)
43. Nakajima, A. et al. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice. J. Immunol. 185, 1887-1893 (2010).
44. Meng, G., Zhang, F., Fuss, I., Kitani, A. & Strober, W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30, 860-874 (2009).
45. Viguier, M., Guigue, P., Pagès, C., Smahi, A. & Bachelez, H. Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations. Ann. Intern. Med. 153, 66-67 (2010).
46. González-López, M. A., Martínez-Taboada, V. M., González-Vela, M. C., Fernández-Llaca, H. & Val-Bernal, J. F. New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra. Br. J. Dermatol. 158, 1146-1148 (2008). (Pubitemid 351521438)